Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kamal Boostani"'
Publikováno v:
Clinical Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Key Clinical Message The differential diagnosis of post‐COVID‐19 syndrome is important in patients with symptoms of biliary obstruction. This patient had severe COVID‐19 who underwent ERCP and mimicked cholangiocarcinoma. Abstract Patients with
Externí odkaz:
https://doaj.org/article/337812c756294620b41d7f3073dbdc06
Autor:
Farahnoosh Farnood, Seyyedeh Mina Hejazian, Kamal Boostani, Alireza Mardomi, Mohammadreza Ardalan
Publikováno v:
Journal of Nephropharmacology, Vol 12, Iss 1, Pp e10519-e10519 (2023)
The incidence of chronic kidney diseases (CKDs) by rare etiologies is growing along with other CKDs. This mini-review discusses the epidemiology, pathogenesis, clinical presentation, and diagnosis of rare kidney disease recurrence after kidney transp
Externí odkaz:
https://doaj.org/article/9b207e18a945470298b7a6840bd3242f
Peritoneal dialysis after failed kidney transplantation; a case series with review of the literature
Publikováno v:
Journal of Nephropharmacology, Vol 11, Iss 2, Pp e10491-e10491 (2022)
Kidney transplantation is a definite treatment for end-stage renal disease (ESRD). However, management of allograft dysfunction has remained a major challenge and some patients return to dialysis after renal transplantation. Studies showed that perit
Externí odkaz:
https://doaj.org/article/492340e7d825438784dfe01e7569a426
Autor:
Kamal Boostani, Hamid Noshad, Farahnoosh Farnood, Haleh Rezaee, Soheil Teimouri, Taher Entezari-Maleki, Reyhane Najafiazar, Azam Hassanpouri-Olia, Afshin Gharekhani
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 9, Iss 1, Pp 174-179 (2019)
Introduction: Medication errors (MEs) are a leading cause of morbidity and mortality, yet they have remained as confusing and underappreciated concept. The complex pharmacotherapy in hospitalized patients and sometimes serious clinical consequences o
Externí odkaz:
https://doaj.org/article/1738a131dd0343568f20e457530867f3
Autor:
Haleh Rezaee, Soheil Teimouri, Kamal Boostani, Azam Hassanpouri-Olia, Afshin Gharekhani, Taher Entezari-Maleki, Farahnoosh Farnood, Hamid Noshad, Reyhane Najafiazar
Publikováno v:
Advanced Pharmaceutical Bulletin
Advanced Pharmaceutical Bulletin, Vol 9, Iss 1, Pp 174-179 (2019)
Advanced Pharmaceutical Bulletin, Vol 9, Iss 1, Pp 174-179 (2019)
Introduction: Medication errors (MEs) are a leading cause of morbidity and mortality, yet they have remained as confusing and underappreciated concept. The complex pharmacotherapy in hospitalized patients and sometimes serious clinical consequences o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::935130053a116b8f762b853caf09b785
https://doi.org/10.15171/apb.2019.020
https://doi.org/10.15171/apb.2019.020
Autor:
Kamal Boostani, Bita Sepehri, Mohammad Hossein Somi, Saleh Azadbakht, Saeed Dastgiri, Nikou Fotouhi, Morteza Bonyadi, Iraj Asvadi Kermani, Roya Dolatkhah, Faris Farassati
Publikováno v:
OncoTargets and therapy
Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran Roya Dolatkhah,1 Mohammad Hossein Somi,2 Iraj Asvadi Kermani,1 Morteza Bonyadi,3 Bita Sepehri,2 Kama
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64acf787ddbf0aacdcd63e92b38249c
https://pubmed.ncbi.nlm.nih.gov/27994469
https://pubmed.ncbi.nlm.nih.gov/27994469